SG/CALL/SARTORIUS STEDIM BIO/180/0.025/20.12.24 Stock

Warrant

F941S

DE000SU227R8

Market Closed - Euronext Paris 12:30:00 2024-06-28 EDT
0.39 EUR -4.88% Intraday chart for SG/CALL/SARTORIUS STEDIM BIO/180/0.025/20.12.24
1 month-55.93%
3 months-84.62%

Comparison chart between the derivative product and it's underlying value

End-of-day quotes
Date Price Change
24-06-28 0.39 -4.88%
24-06-27 0.41 -8.89%
24-06-26 0.45 +2.27%
24-06-25 0.44 -6.38%
24-06-24 0.47 +6.82%

Real-time Euronext Paris

Last update June 28, 2024 at 12:30 pm

More quotes

Static data

Product typePlain-Vanilla-Warrants
Buy / SellCALL
Underlying SARTORIUS STEDIM BIOTECH
IssuerLogo Issuer Société Générale Société Générale
F941S
ISINDE000SU227R8
Date issued 2023-12-01
Strike 180
Maturity 2024-12-20 (173 Days)
Parity 40 : 1
Emission price 1.63
Emission volume N/A
Settlement cash
Currency EUR

Technical Indicators

Highest since issue 2.905
Lowest since issue 0.375
Spread 0.02
Spread %5.00%

Company Profile

Sartorius Stedim Biotech is a leading provider of cutting-edge equipment and services for the development, quality assurance and production processes of the biopharmaceutical industry. Its integrated solutions covering fermentation, filtration, purification, fluid management and lab technologies are supporting the biopharmaceutical industry around the world to develop and produce drugs safely, timely and economically. For next generation processes, Sartorius Stedim Biotech focuses on single-use technologies and value-added services to meet the rapidly changing technology requirements of the industry it serves. Strongly rooted in the scientific community and closely allied with customers and technology partners, the company is dedicated to its philosophy of turning science into solutions on a daily basis. With its own manufacturing and R&D sites in Europe, North America and Asia and a global network of sales companies, Sartorius Stedim Biotech enjoys a worldwide presence. Its key manufacturing and R&D site is in Germany.
Sector
-
More about the company

Ratings for Sartorius Stedim Biotech

Trading Rating
Investor Rating
ESG Refinitiv
B
More Ratings

Consensus: Sartorius Stedim Biotech

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
12
Last Close Price
153.3 EUR
Average target price
247.2 EUR
Spread / Average Target
+61.23%
Consensus
  1. Stock Market
  2. Warrants
  3. F941S Warrant